Cargando…

Estimation of Health State Utility Values in Fabry Disease Using Vignette Development and Valuation

Background: Health state utilities are measures of health-related quality of life that reflect the value placed on improvements in patients’ health status and are necessary for estimation of quality-adjusted life-years. Health state utility data on Fabry disease (FD) are limited. In this study we us...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hughes, Derralynn, Lenny, Andrew, Shah, Koonal, Longworth, Louise, Devercelli, Giovanna, Ayodele, Olulade
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Columbia Data Analytics, LLC 2023
Materias:	Hereditary Genetic Disorders
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10095067/ https://www.ncbi.nlm.nih.gov/pubmed/37064293 http://dx.doi.org/10.36469/001c.71344

Ejemplares similares

Clinical Characteristics and Healthcare Resource Utilization for Patients with Mucopolysaccharidosis II (MPS II) in the United States: A Retrospective Chart Review
por: Ayodele, Olulade, et al.
Publicado: (2022)

Quality of Life with Late-Onset Pompe Disease: Qualitative Interviews and General Public Utility Estimation in the United Kingdom
por: Hubig, Lena, et al.
Publicado: (2023)

Hereditary angioedema patients would prefer newer-generation oral prophylaxis
por: Geba, Daniela, et al.
Publicado: (2021)

Patient Survey of current water Intake practices in autosomal dominant Polycystic kidney disease: the SIPs survey
por: El-Damanawi, Ragada, et al.
Publicado: (2017)

Should eculizumab be discontinued in patients with atypical hemolytic uremic syndrome?
por: Rodriguez, Eva, et al.
Publicado: (2017)

Current evidence on the discontinuation of eculizumab in patients with atypical haemolytic uraemic syndrome
por: Macia, Manuel, et al.
Publicado: (2017)

Adapting preference-based utility measures to capture the impact of cancer treatment-related symptoms
por: Shah, Koonal K., et al.
Publicado: (2021)

Euthanasia, religiosity and the valuation of health states: results from an Irish EQ5D5L valuation study and their implications for anchor values
por: Barry, Luke, et al.
Publicado: (2018)

Vignette of Vigna domestication: From archives to genomics
por: Verma, Sachin Kumar, et al.
Publicado: (2022)

Fabry disease and incidence of cancer
por: Bird, Sarah, et al.
Publicado: (2017)

EuroQol Protocols for Time Trade-Off Valuation of Health Outcomes
por: Oppe, Mark, et al.
Publicado: (2016)

Development and validation of Gaucher disease type 1 (GD1)-specific patient-reported outcome measures (PROMs) for clinical monitoring and for clinical trials
por: Elstein, Deborah, et al.
Publicado: (2022)

Time and lexicographic preferences in the valuation of EQ-5D-Y with time trade-off methodology
por: Lipman, Stefan A., et al.
Publicado: (2022)

Fabry Disease: A Atypical Presentation
por: Ferreira Tátá, Cláudia, et al.
Publicado: (2021)

Correction to: Time and lexicographic preferences in the valuation of EQ-5D-Y with time trade-off methodology
por: Lipman, Stefan A., et al.
Publicado: (2022)

Clinical and Molecular Characterization of ALG1-CDG
por: Dhamija, Radhika, et al.
Publicado: (2016)

The Genetics of Febrile Seizures
por: Ram, Dipak, et al.
Publicado: (2015)

Incidental Findings: The Importance of Pretest Counseling
por: Buchtel, Kathryn M., et al.
Publicado: (2015)

Epileptic Encephalopathy Due to BRAT1 Pathogenic Variants
por: Srivastava, Siddharth, et al.
Publicado: (2016)

Ocular Manifestation of CACNA1A Pathogenic Variants
por: Reinson, Karit, et al.
Publicado: (2016)

Neurocognitive Functions and Behavior in Joubert Syndrome
por: Poretti, Andrea, et al.
Publicado: (2016)

Genetic Testing Requires NGS and Sanger Methodologies
por: Jennings, Lawrence J., et al.
Publicado: (2016)

Neurotransmitters and Sodium Channelopathies; Possible Link?
por: Hammer, Michael F., et al.
Publicado: (2017)

STXBP1-Related Developmental and Epileptic Encephalopathy
por: Wild, Brittani, et al.
Publicado: (2019)

Genetic Diagnosis of Cockayne Syndrome
por: Patel, Rifali
Publicado: (2020)

Neurologic Features with Pathogenic Copy Number Variants
por: Coryell, Jason
Publicado: (2020)

Toward a consensus in the laboratory diagnostics of Fabry disease - recommendations of a European expert group
por: Gal, Andreas, et al.
Publicado: (2011)

Stroke and Fabry Disease: A Review of Literature
por: Mishra, Vinayak, et al.
Publicado: (2020)

Clinical prodromes of neurodegeneration in Anderson-Fabry disease
por: Löhle, Matthias, et al.
Publicado: (2015)

Long-term effectiveness of agalsidase alfa enzyme replacement in Fabry disease: A Fabry Outcome Survey analysis
por: Beck, Michael, et al.
Publicado: (2015)

Binary Choice Health State Valuation and Mode of Administration: Head-to-Head Comparison of Online and CAPI
por: Mulhern, Brendan, et al.
Publicado: (2013)

Novel GLA Mutation Promotes Intron Inclusion Leading to Fabry Disease
por: Varela, Patrícia, et al.
Publicado: (2019)

A Novel Rapid MALDI-TOF-MS-Based Method for Measuring Urinary Globotriaosylceramide in Fabry Patients
por: Alharbi, Fahad J., et al.
Publicado: (2016)

A Novel α-Galactosidase A Splicing Mutation Predisposes to Fabry Disease
por: Li, Ping, et al.
Publicado: (2019)

Case Report: First Two Identified Cases of Fabry Disease in Central Asia
por: Cainelli, Francesca, et al.
Publicado: (2021)

Measures to mitigate disruption due to the COVID-19 pandemic of the MODIFY phase 3 pivotal trial in patients with Fabry disease
por: Frey, Aline, et al.
Publicado: (2021)

Utility of Repetitive Nerve Stimulation in Myopathies
por: Schwaede, Abigail, et al.
Publicado: (2020)

Seizure Action Plans and Health Care Utilization
por: Albert, Dara V.F., et al.
Publicado: (2015)

Discordant renal progression of Fabry disease in male monozygotic twins: a case report
por: Lee, Do-Yun, et al.
Publicado: (2023)

Estimation of Health-Related Utilities for (177)Lu-DOTATATE in GEP-NET Patients Using Utilities Mapped from EORTC QLQ-C30 to EQ-5D-3L and QLU-C10D Utilities
por: Soare, Ioana-Alexandra, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qf1cmo7v162mfbo4if5jin8icm